Back

The Viborg Vascular randomised screening trial

28 August 2017 (11:54 - 12:04)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Clinical Trials 2 Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Jes Lindholt

Odense University Hospital, Odense (Denmark)

17 More presentations in this session

Presentation thumbnail
SPYRAL HTN OFF-MED Study
Professor M. Boehm (Homburg, DE)
Slides Video
Presentation thumbnail
Discussant review: SPYRAL HTN OFF-MED Study
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Panel discussion.
Presentation thumbnail
Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
Professor M. Ezekowitz (Philadelphia, US)
Slides Video
Presentation thumbnail
Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
Professor J. Nielsen (Aarhus, DK)
Slides Video

Access the full session

Session thumbnail
Hot Line: Late-Breaking Clinical Trials 2

The Event

Event poster

ESC Congress 2017

28 August 2017 11:54 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources